Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
On July 1, Pfizer urged a US appeals court not to revisit its decision to bar an anti-affirmative action group's challenge to its diversity fellowship. The pharmaceutical company argued that the group failed to name individuals who were allegedly harmed by the fellowship.
EU Court Rejects Appeals Over Perindopril Settlements https://t.co/Z0Q0P7HqXF #PinkSheet
The schools have long produced an outsized share of the nation’s Black PhDs, doctors and lawyers. Now, the end of affirmative action and threats to DEI are giving them a new boost. https://t.co/WOvZGXUuDc
Sun Pharmaceutical's win against claims the company conspired to hinder the release of a generic cholesterol-reducing drug raises the standard for plaintiffs to win class status in pay-for-delay cases. https://t.co/Ote963SMBJ
